Terra Biological LLC   Report issue

For profit Phase 3
Founded: San Diego CA United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2012
NCT01741701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Terra Biological LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

oxaloacetate (6 trials)

Drugs in Other Trials (2)

oryza sativa (2 trials)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 3